Fetal microchimerism in kidney biopsies of lupus nephritis patients may be associated with a beneficial effect

Arthritis Research and Therapy

Volumn 17, Issue 1, 2015, Pages

  Florim, Greiciane ^a   Caldas, Heloisa C ^a   de Melo, Julio ^a   Baptista, Maria Alice ^a,b   Fernandes, Ida ^a,b   Savoldi Barbosa, Marcela ^c   Goldman, Gustavo H ^c   Abbud Filho, Mario ^a,b,d  

^a Laboratory of Immunology and Transplantation Experimental LITEX   (Brazil)

^b HOSPITAL DE BASE   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Institute of Urology and Nephrology   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GENOMIC DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FETUS CELL; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MICROCHIMERIC MALE FETAL CELL; PREGNANCY; PROLIFERATIVE GLOMERULONEPHRITIS; REAL TIME POLYMERASE CHAIN REACTION; Y CHROMOSOME; BLOOD; CASE CONTROL STUDY; CHIMERA; EPIDEMIOLOGY; FETUS; GENETIC PREDISPOSITION; GENETICS; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; NONPARAMETRIC TEST; PATHOLOGY; PREGNANCY OUTCOME; PREVALENCE; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; SYSTEMIC LUPUS ERYTHEMATOSUS;

BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CHIMERISM; CREATININE; FEMALE; FETUS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; LINEAR MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY OUTCOME; PREVALENCE; RISK ASSESSMENT; SEX FACTORS; STATISTICS, NONPARAMETRIC;

EID: 84928606794     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-015-0615-4     Document Type: Article

References (32)

1. Seshan SV, Jennette JC. Renal disease in systemic lupus erythematosus with emphasis on classification of lupus glomerulonephritis: advances and implications. Arch Pathol Lab Med. 2009;133:233-48.
2. Appel GB, Cohen DJ, Pirani CL, Meltzer JI, Estes D. Long-term follow-up of patients with lupus nephritis: a study based on the classification of the World Health Organization. Am J Med. 1987;83:877-85.
3. Crispín JC, Liossis SN, Kis-Toth K, Lieberman LA, Kyttaris VC, Juang YT, et al. Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med. 2010;16:47-57.
4. Miyashita Y, Ono M, Ono M, Ueki H, Kurasawa K. Y chromosome microchimerism in rheumatic autoimmune disease. Ann Rheum Dis. 2000;64:605-12.
5. Nelson JL. The otherness of self: microchimerism in health and disease. Trends Immunol. 2012;33:421-7.
6. Sarkar K, Miller FW. Possible roles and determinants of microchimerism in autoimmune and other disorders. Autoimmun Rev. 2004;3:454-63.
7. Adams KM, Nelson JL. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA. 2004;291:1127-31.
8. D'Cruz DP, Khamashta M, Hughes GR. Systemic lupus erythematosus. Lancet. 2007;369:587-96.
9. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A. 1996;93:705-8.
10. Via CS, Shearer GM. T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. Immunol Today. 1988;9:207-13.
11. Mosca M, Curcio M, Lapi S, Valentini G, D'Angelo S, Rizzo G, et al. Correlations of Y chromosome microchimerism with disease activity in patients with SLE: analysis of preliminary data. Ann Rheum Dis. 2003;62:651-4.
12. Kremer Hovinga IC, Koopmans M, Baelde HJ, van der Wal AM, Sijpkens YW, de Heer E, et al. Chimerism occurs twice as often in lupus nephritis as in normal kidneys. Arthritis Rheum. 2006;54:2944-50.
13. Kremer Hovinga IC, Koopmans M, Grootscholten C, van der Wal AM, Bijl M, Derksen RH, et al. Pregnancy, chimerism and lupus nephritis: a multi-centre study. Lupus. 2008;17:541-7.
14. Abbud FM, Pavarino-Bertelli EC, Alvarenga MP, Fernandes IM, Toledo RA, Tajara EH, et al. Systemic lupus erythematosus and microchimerism in autoimmunity. Transplant Proc. 2002;34:2951-2.
15. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1992;25:1271-7.
16. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65:521-30. A published erratum appears in Kidney Int. 2004;65:1132.
17. Pollack VE, Pirani CL, Schawartz FD. The natural history of the renal manifestations of systemic lupus erythematosus. J Lab Clin Med. 1964;63:537-50.
18. Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, et al. Prognostic factors in lupus nephritis, contribution of renal histologic data. Am J Med. 1983;75:382-91.
19. Lo YMD, Lau TK, Chan LY, Leung TN, Chang AM. Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem. 2000;46:1301-9.
20. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988;239:487-91.
21. Fugazzola L, Cirello V, Beck-Peccoz P. Fetal microchimerism as an explanation of disease. Nat Rev Endocrinol. 2011;7:89-97.
22. Gannagé M, Amoura Z, Lantz O, Piette JC, Caillat-Zucman S. Fetomaternal microchimerism in connective tissue diseases. Eur J Immunol. 2002;32:3405-13.
23. Kekow M, Barleben M, Drynda S, Jakubiczka S, Kekow J, Brune T. Long-term persistence and effects of fetal microchimerism on disease onset and status in a cohort of women with rheumatoid arthritis and systemic lupus erythematosus. BMC Musculoskelet Disord. 2013;14:325.
24. Kremer Hovinga IC, Koopmans M, Baelde HJ, de Heer E, Bruijn JA, Bajema IM. Tissue chimerism in systemic lupus erythematosus is related to injury. Ann Rheum Dis. 2007;66:1568-73.
25. Johnson KL, McAlindon TE, Mulcahy E, Bianchi DW. Microchimerism in a female patient with systemic lupus erythematosus. Arthritis Rheum. 2001;44:2107-11.
26. Khosrotehrani K, Mery L, Aractingi S, Bianchi DW, Johnson KL. Absence of fetal cell microchimerism in cutaneous lesions of lupus erythematosus. Ann Rheum Dis. 2005;64:159-60.
27. Stevens AM. Microchimeric cells in systemic lupus erythematosus: targets or innocent bystanders? Lupus. 2006;15:820-6.
28. Lissauer D, Piper KP, Moss PA, Kilby MD. Persistence of fetal cells in the mother: friend or foe? BJOG. 2007;114:1321-5.
29. O'Donoghue K, Chan J, de la Fuente J, Kennea N, Sandison A, Anderson JR, et al. Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet. 2004;364:179-82.
30. Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells. 2007;25:2896-902.
31. Lam GK, Petri M. Assessment of systemic lupus erythematosus. Clin Exp Rheumatol. 2005;23:120-32.
32. Contreras G, Pardo V, Cely C, Borja E, Hurtado A, De La Cuesta C, et al. Factors associated with poor outcomes in patients with lupus nephritis. Lupus. 2005;14:890-5.